JOINT FILING AGREEMENT
Exhibit 99.1
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the persons named below agrees to the joint filing of a Statement on Schedule 13G (including amendments thereto) with respect to the shares of Ordinary Shares, par value £0.01 per share, of Akari Therapeutics, Plc, and further agree that this Joint Filing Agreement shall be included as an exhibit to such joint filings.
This Joint Filing Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original instrument, but all of such counterparts together shall constitute one agreement.
In evidence thereof, the undersigned, being duly authorized, hereby execute this Joint Filing Agreement as of July 2, 2020.
BY: ASPIRE CAPITAL PARTNERS, LLC BY: SGM HOLDINGS CORP. |
ASPIRE CAPITAL PARTNERS, LLC BY: SGM HOLDINGS CORP. | |||||||
By: | /s/ Xxxxxx X. Xxxxxx |
By: | /s/ Xxxxxx X. Xxxxxx | |||||
Name: | Xxxxxx X. Xxxxxx | Name: | Xxxxxx X. Xxxxxx | |||||
Title: | President | Title: | President | |||||
SGM HOLDINGS CORP. | RED CEDAR CAPITAL CORP. | |||||||
By: | /s/ Xxxxxx X. Xxxxxx |
By: | /s/ Xxxx X. Xxxxx | |||||
Name: | Xxxxxx X. Xxxxxx | Name: | Xxxx X. Xxxxx | |||||
Title: | President | Title: | President | |||||
CHRISKO INVESTORS, INC. | WML VENTURES CORP. | |||||||
By: | /s/ Xxxxxxxx Xxxxxxxxxxxxx |
By: | /s/ Xxxxxxx X. Xxxxx III | |||||
Name: | Xxxxxxxx Xxxxxxxxxxxxx | Name: | Xxxxxxx X. Xxxxx III | |||||
Title: | President | Title: | President | |||||
XXXXXX X. XXXXXX | XXXX X. XXXXX | |||||||
/s/ Xxxxxx X. Xxxxxx |
/s/ Xxxx X. Xxxxx | |||||||
XXXXXXXX XXXXXXXXXXXXX | XXXXXXX X. XXXXX III | |||||||
/s/ Xxxxxxxx Xxxxxxxxxxxxx |
/s/ Xxxxxxx X. Xxxxx III |